「th」の検索結果
184件：101～105件目を表示
-
Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Sen...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
Announcement Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Sen...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
. Launch and Distribution of “MIEr for BeelineMED” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of “MIEr for BeelineMED” in Japan. MIEr for BeelineMED is cap...
https://www.senju.co.jp/system/files/content_news/2025-02/ENG_20250220.pdf -
Publications | Research & Development | SENJU Pharmaceutica
Double-Masked, Placebo-Controlled Phase 1/2 Study of a TRPV1 Antagonist SJP-0132 in Participants With Dry Eye Disease Tomoyuki Wada1, Kazunori Omatsu1, Stephen C. Pflugfelder2 1: Senju Pharmaceutical...
http://www.senju.co.jp/english/rd/thesis/ -
お知らせ | 千寿製薬株式会社
e 1, 2026 Launch of Distribution of 3in1Smart and SPM-700（PDF） April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF...
http://www.senju.co.jp/english/news/